Med Clin North Am. 2007 Nov;91(6):1091-105, viii-ix.

Prevention of diabetes development in those with the metabolic syndrome.

Source

Warren Alpert Medical School of Brown University, 1 Hoppin Street, Suite 200, Providence, RI 02860, USA.

Abstract

Metabolic syndrome is characterized by abnormal glucose levels, central obesity, hypertension, elevated triglycerides, and low HDL cholesterol. This article reviews available data regarding the impact of lifestyle modification and drug therapies on the progression to diabetes in high risk individuals, such as those with hypertension, dyslipidemia, obesity, and prediabetes. Lifestyle and pharmacological interventions may alter metabolic parameters and impact progression to diabetes. However, the cost-effectiveness of these interventions are unclear.

PMID:: 17964911; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Anti-Obesity Agents

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes. [Clin Cornerstone. 2006]
Review Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes.
Stone NJ. Clin Cornerstone. 2006; 8 Suppl 1:S15-20.
Review [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]. [G Ital Cardiol (Rome). 2008]
Review [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
Vanuzzo D, Pilotto L, Mirolo R, Pirelli S. G Ital Cardiol (Rome). 2008 Apr; 9(4 Suppl 1):6S-17S.
[Pharmacological therapy of obesity]. [G Ital Cardiol (Rome). 2008]
[Pharmacological therapy of obesity].
Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. G Ital Cardiol (Rome). 2008 Apr; 9(4 Suppl 1):83S-93S.
Review Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome. [Mt Sinai J Med. 2010]
Review Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome.
Lukacova-Zib I, Gopalakrishnan G. Mt Sinai J Med. 2010 Sep-Oct; 77(5):524-32.
Review Metabolic syndrome: controversial but useful. [Cleve Clin J Med. 2007]
Review Metabolic syndrome: controversial but useful.
Stolar M. Cleve Clin J Med. 2007 Mar; 74(3):199-202, 205-8.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Prevention of diabetes development in those with the metabolic syndrome.
Prevention of diabetes development in those with the metabolic syndrome.
Med Clin North Am. 2007 Nov ;91(6):1091-105, viii-ix.

PubMed
The state-of-the-science: access to postacute care rehabilitation services. A re...
The state-of-the-science: access to postacute care rehabilitation services. A review.
Arch Phys Med Rehabil. 2007 Nov ;88(11):1513-21.

PubMed
Exacerbation of wood smoke-induced acute lung injury by mechanical ventilation u...
Exacerbation of wood smoke-induced acute lung injury by mechanical ventilation using moderately high tidal volume in mice.
Respir Physiol Neurobiol. 2008 Jan 1 ;160(1):99-108. Epub 2007 Sep 22 .

PubMed
Pain in the elbow: a rare presentation of skeletal tuberculosis.
Pain in the elbow: a rare presentation of skeletal tuberculosis.
J Shoulder Elbow Surg. 2008 Jan-Feb ;17(1):e19-21. Epub 2007 Oct 26 .

PubMed
RANK ligand as a therapeutic target for bone metastases and multiple myeloma.
RANK ligand as a therapeutic target for bone metastases and multiple myeloma.
Cancer Treat Rev. 2008 Feb ;34(1):92-101. Epub 2007 Oct 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: